SCHEMBL21083345

SCHEMBL21083345

Cc1ccc2ncc(S(N)(=O)=O)n2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 1/20 0.53
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
TNF P01375 2/20 0.46
RXFP1 Q9HBX9 1/20 0.45
KDM4E B2RXH2 1/20 0.43
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA3 P07451 1/20 0.37
CA6 P23280 1/20 0.37
CA5A P35218 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA5B Q9Y2D0 1/20 0.37
MET P08581 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21084307 0.80 TGFBR1 (0.47) TGFBR1TNFCA12CA2CA9
SCHEMBL23873085 0.80 TGFBR1 (0.47) TGFBR1TNFALDH1A1CA12CA1
SCHEMBL23872984 0.80 TGFBR1 (0.47) TGFBR1CYP1A2CYP2C9TNFRXFP1
SCHEMBL23872985 0.75 TGFBR1 (0.46) TGFBR1TNFRXFP1ALDH1A1CA12
SCHEMBL21083341 0.73 CYP1A2 (0.53) TGFBR1CYP1A2CYP2C9RXFP1KDM4E
SCHEMBL13692821 0.73 CYP1A2 (0.53) CYP1A2CYP2C9RXFP1KDM4EGLA
SCHEMBL20125127 0.73 CYP1A2 (0.53) CYP1A2CYP2C9RXFP1KDM4EGLA
SCHEMBL9525882 0.72 TGFBR1 (0.46) TGFBR1TNFKDM4EGLAGAA
SCHEMBL10238918 0.72 CYP1A2 (0.56) TGFBR1CYP1A2CYP2C9KDM4EGLA
SCHEMBL24349173 0.71 CYP1A2 (0.47) TGFBR1CYP1A2CYP2C9RXFP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3492461-A1 NITROGENOUS HETEROCYCLIC AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION THEREOF Shanghai Yingli Pharmaceutical Co. Ltd. (CN) 2019-06-05 EP disclosed